Long-Term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy

Authors
Publication date
1 January 2017
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi

    Abstract

    We previously described the possible clinical effects of early monotherapeutic IV-immunomodulation (IVIg) treatment in sporadic1 but not in postH1N1 vaccination narcolepsy type 1 (NT1).2 We report here an early post-H1N1 vaccination NT1 case treated with combined immunomodulation of IVIg and methylprednisolone, and a comparable sporadic NT1 case

      Similar works

      Full text

      thumbnail-image

      Available Versions

      NORA - Norwegian Open Research Archives

      redirect
      oaioai:www.duo.uio.no:10852/63248
      Last time updated on 04/11/2018

      NORA - Norwegian Open Research Archives

      redirect
      oaioai:ntnuopen.ntnu.no:11250/250...
      Last time updated on 14/10/2021